Literature DB >> 7671314

Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency.

M E Elder1, T J Hope, T G Parslow, D T Umetsu, D W Wara, M J Cowan.   

Abstract

During ontogeny, T lymphocytes are selected for CD4 or CD8 expression in part by their ability to signal properly through the TCR. Transmission of such signals requires the activation of specific cytoplasmic protein tyrosine kinases (PTKs) which lead to T-cell activation through poorly understood mechanisms. Recently, mutations in one such PTK, called ZAP-70, have been shown to be responsible for a rare, autosomal recessive form of severe combined immunodeficiency (SCID) in humans. This distinctive SCID syndrome is characterized by the selective absence of peripheral CD8+ T cells and by abundant circulating CD4+ T cells that fail to respond to TCR-mediated stimuli in vitro. In this report, we describe in detail the clinical and laboratory findings in one patient with ZAP-70 deficiency and discuss the insights provided by this disorder into the pathways of TCR signal transduction and T-cell development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671314     DOI: 10.1006/cimm.1995.1193

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

Review 1.  Diagnosis of severe combined immunodeficiency.

Authors:  A R Gennery; A J Cant
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

2.  Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred.

Authors:  A S O'Marcaigh; J M Puck; A E Pepper; K De Santes; M J Cowan
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 3.  ZAP70: a master regulator of adaptive immunity.

Authors:  Alain Fischer; Capucine Picard; Karine Chemin; Stéphanie Dogniaux; Françoise le Deist; Claire Hivroz
Journal:  Semin Immunopathol       Date:  2010-02-05       Impact factor: 9.623

4.  Mechanism of activation for Zap-70 catalytic activity.

Authors:  P V LoGrasso; J Hawkins; L J Frank; D Wisniewski; A Marcy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.

Authors:  S Toyabe; A Watanabe; W Harada; T Karasawa; M Uchiyama
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

6.  Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.

Authors:  Jason L Pugh; Neda Nemat-Gorgani; Paul J Norman; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

7.  Negative Regulation of Zap70 by Lck Forms the Mechanistic Basis of Differential Expression in CD4 and CD8 T Cells.

Authors:  Hassan Damen; Christian Tebid; Melissa Viens; Denis-Claude Roy; Vibhuti P Dave
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

8.  Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.

Authors:  Shilu Amin; Meagan Walsh; Caroline Wilson; Anton E Parker; David Oscier; Elaine Willmore; Derek Mann; Jelena Mann
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

Review 9.  Modeling hematopoietic disorders in zebrafish.

Authors:  Martina Konantz; Christoph Schürch; Pauline Hanns; Joëlle S Müller; Loïc Sauteur; Claudia Lengerke
Journal:  Dis Model Mech       Date:  2019-09-06       Impact factor: 5.758

Review 10.  Gene therapy for severe combined immunodeficiency: are we there yet?

Authors:  Marina Cavazzana-Calvo; Alain Fischer
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.